Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
To assess the effect of dienogest on recurrence of ovarian endometriomas and severity of pain after laparoscopic surgery, a retrospective study of 81 patients was performed at three institutions in Osaka, Japan. Patients had a six-month minimum follow-up after laparoscopic surgery for ovarian endometriomas performed between June 2012 and August 2014. Patients who chose to receive 2 mg dienogest daily and those who were managed expectantly postoperatively were included. Recurrence was defined as the presence of endometriomas of more than 2 cm. A visual analog scale (VAS) was used to score the intensity of pelvic pain. The cumulative recurrence rate and absolute VAS score changes between the baseline and at 6, 12, 18 and 24 months after the start of administration were evaluated in both groups. The recurrence rate was 16.5% and 24.0% in the expectant management group at 12 and 24 months, respectively. No recurrences occurred in the dienogest treatment group. The rate of VAS score reduction was significantly higher in the dienogest than in the expectant management group. Dienogest is effective on the recurrence of ovarian endometrioma and relieving pelvic pain after laparoscopic surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381 · cited 2×
“have reported that long-term dienogest is well tolerated and has a favorable safety profile, including a low incidence of hypoestrogenic effects and minimal change in bone mineral density [10].”
BackgroundStrowitzki, T., Faustmann, T., Gerlinger, C., & Seitz, C. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.04.002 · Cited by 227 · cited 1×
“In a placebo-controlled study, 12 weeks treatment with dienogest resulted in significant VAS score reduction in patients with endometriosis-associated pelvic pain [16].”
BackgroundRecurrence of ovarian endometrioma after laparoscopic excision
Koga, K., Takemura, Y., Osuga, Y., Yoshino, O., Hirota, Y., Hirata, T., Morimoto, C., Harada, M., Yano, T., & Taketani, Y. (2006) · Human Reproduction · doi:10.1093/humrep/del125 · Cited by 203 · cited 1×
“Laparoscopic surgery was performed as previously described [1,12].”
MethodReduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
Petraglia, F., Hornung, D., Seitz, C., Faustmann, T., Gerlinger, C., Luisi, S., Lazzeri, L., & Strowitzki, T. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1941-7 · Cited by 200
Postoperative oral contraceptive exposure and risk of endometrioma recurrence
Vercellini, P., Somigliana, E., Daguati, R., Vigano, P., Meroni, F., & Crosignani, P. G. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.11.010 · Cited by 196
Sasagawa, S., Shimizu, Y., Kami, H., Takeuchi, T., Mita, S., Imada, K., Kato, S., & Mizuguchi, K. (2008) · Steroids · doi:10.1016/j.steroids.2007.10.003 · Cited by 177 · cited 1×
“synthetic oral progestin, that is, approved for the treatment of endometriosis [4].”
BackgroundCosson, M., Querleu, D., Donnez, J., Madelenat, P., Konincks, P., Audebert, A., & Manhes, H. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03270-8 · Cited by 153
Patterns of and Risk Factors for Recurrence in Women With Ovarian Endometriomas
Liu, X., Yuan, L., Shen, F., Zhu, Z., Jiang, H., & Guo, S.-W. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000265215.87717.8b · Cited by 146 · cited 1×
“Our data are in agreement with those of a previous study in which the recurrence rate increased gradually up to 30 months after surgery and decreased thereafter [13].”
ResultStrowitzki, T., Faustmann, T., Gerlinger, C., Schumacher, U., Ahlers, C., & Seitz, C. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s77202 · Cited by 120 · cited 1×
“In one randomized controlled trial, dienogest was well tolerated and had a favorable safety profile465 weeks in patients with endometriosis [14].”
BackgroundSeitz, C., Gerlinger, C., Faustmann, T., & Strowitzki, T. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.07.1085 · Cited by 18
Cited by
Zakhari, A., Edwards, D., Ryu, M., Matelski, J. J., Bougie, O., & Murji, A. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2020.05.007 · Cited by 86
Burghaus, S., Schäfer, S. D., Beckmann, M. W., Brandes, I., Brünahl, C., Chvatal, R., Drahoňovský, J., Dudek, W., Ebert, A. D., Fahlbusch, C., et al. (2021) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1380-3693 · Cited by 69
Song, S. Y., Park, M., Lee, G. W., Lee, K. H., Chang, H. K., Kwak, S. M., & Yoo, H. J. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.10.014 · Cited by 24
Seo, J.-W., Lee, D.-Y., Kim, S. E., Yoon, B.-K., & Choi, D. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.02.032 · Cited by 18
Metadata
- Authors
- Adachi, K., Takahashi, K., Nakamura, K., Otake, A., Sasamoto, N., Miyoshi, Y., Shioji, M., Yamamoto, Y., Fujitani, M., Wakimoto, A., Tokuhira, A., Kobayashi, E., Yoshimura, A., Sawada, K., & Kimura, T.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2016-02-18
- Volume
- 32
- Issue
- 8
- Pages
- 646-649
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2289043567
- Cited by
- 53
- References
- 10
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas. https://app.cochat.ai/papers/10.3109/09513590.2016.1147547
- The paper
- Adachi, K., Takahashi, K., Nakamura, K., Otake, A., Sasamoto, N., Miyoshi, Y., Shioji, M., Yamamoto, Y., Fujitani, M., Wakimoto, A., Tokuhira, A., Kobayashi, E., Yoshimura, A., Sawada, K., & Kimura, T. (2016). Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas. Gynecological Endocrinology. https://doi.org/10.3109/09513590.2016.1147547
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.